Effect of the p38 kinase inhibitor, SE 203580, on allergic airway inflammation in the rat
Effect of the p38 kinase inhibitor, SE 203580, on allergic airway inflammation in the rat
复制标题
DOI:
10.1038/sj.bjp.0703605
复制
发表时间:
2000-09-01
影响因子:
7.3
通讯作者:
Sargent, CA
中科院分区:
文献类型:
--
作者:
Escott, KJ;Belvisi, MG;Sargent, CA
Tumour necrosis factor-alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) have been implicated in the pathogenesis of asthma. The p38 kinase inhibitor, SE 203580 inhibits TNF-alpha and IL-1 beta production in vitro and in vivo. In this study the effect of SE 203580 on allergen-induced airway TNF-a production and inflammatory cell recruitment was investigated in sensitized Brown Norway rats. The allergen-induced increase in bronchoalveolar lavage (BAL) TNF-alpha was inhibited by SE 203580 at every dose tested (10-100 mg kg(-1), p.o.). In contrast, neither ovalbumin-induced eosinophilia or neutrophilia were inhibited by SE 203580 (10-100 mg kg(-1), p.o.). In conclusion, SE 203580 inhibits BAL TNF-alpha production by 95% without inhibiting either antigen-induced airway eosinophilia or neutrophilia. This data suggests that either the residual TNF-alpha is sufficent to drive allergen-induced inflammatory cell recruitment into the lung or that TNF-alpha is not involved in allergen-induced inflammatory cell recruitment.